Celis E - Search Results

1

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.

Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H. Hirata-Nozaki Y, et al. Among authors: celis e. J Transl Med. 2019 Jun 20;17(1):207. doi: 10.1186/s12967-019-1957-5. J Transl Med. 2019. PMID: 31221178 Free PMC article.

2

Synthetic antigenic peptides as a new strategy for immunotherapy of cancer.

Appella E, Loftus DJ, Sakaguchi K, Sette A, Celis E. Appella E, et al. Among authors: celis e. Biomed Pept Proteins Nucleic Acids. 1995;1(3):177-84. Biomed Pept Proteins Nucleic Acids. 1995. PMID: 9346850 Review.

3

MHC-binding peptides as immunotherapeutics for cancer.

Kobayashi H, Kennedy R, Lu J, Davila E, Celis E. Kobayashi H, et al. Among authors: celis e. Immunol Invest. 2000 May;29(2):105-10. doi: 10.3109/08820130009062291. Immunol Invest. 2000. PMID: 10854176 No abstract available.

4

Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.

Kobayashi H, Wood M, Song Y, Appella E, Celis E. Kobayashi H, et al. Among authors: celis e. Cancer Res. 2000 Sep 15;60(18):5228-36. Cancer Res. 2000. PMID: 11016652

5

Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.

Kobayashi H, Song Y, Hoon DS, Appella E, Celis E. Kobayashi H, et al. Among authors: celis e. Cancer Res. 2001 Jun 15;61(12):4773-8. Cancer Res. 2001. PMID: 11406551

6

Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.

Kobayashi H, Lu J, Celis E. Kobayashi H, et al. Among authors: celis e. Cancer Res. 2001 Oct 15;61(20):7577-84. Cancer Res. 2001. PMID: 11606397

7

Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.

Kobayashi H, Kimura S, Aoki N, Sato K, Celis E, Katagiri M. Kobayashi H, et al. Among authors: celis e. Immunogenetics. 2001 Oct;53(8):626-33. doi: 10.1007/s00251-001-0379-7. Epub 2001 Nov 9. Immunogenetics. 2001. PMID: 11797095

8

Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function.

Giuntoli RL 2nd, Lu J, Kobayashi H, Kennedy R, Celis E. Giuntoli RL 2nd, et al. Among authors: celis e. Clin Cancer Res. 2002 Mar;8(3):922-31. Clin Cancer Res. 2002. PMID: 11895927

9

Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope.

Omiya R, Buteau C, Kobayashi H, Paya CV, Celis E. Omiya R, et al. Among authors: celis e. J Immunol. 2002 Aug 15;169(4):2172-9. doi: 10.4049/jimmunol.169.4.2172. J Immunol. 2002. PMID: 12165547

10

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

Kobayashi H, Omiya R, Ruiz M, Huarte E, Sarobe P, Lasarte JJ, Herraiz M, Sangro B, Prieto J, Borras-Cuesta F, Celis E. Kobayashi H, et al. Among authors: celis e. Clin Cancer Res. 2002 Oct;8(10):3219-25. Clin Cancer Res. 2002. PMID: 12374692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters